Postoperative radiosurgery for malignant spinal tumors

Neurosurgery
Jack P RockMark Rosenblum

Abstract

Although, as a primary therapy, radiosurgery for spinal tumors is becoming more common in clinical practice and is associated with encouraging clinical results, we wanted to evaluate outcomes after radiosurgery in a series of postoperative patients. We examined the medical records of 18 postoperative patients who received radiosurgical treatment to their residual spinal tumors: metastatic carcinoma (10), sarcoma (3), multiple myeloma/plasmacytoma (4), and giant cell tumor (1). Marginal radiosurgical doses ranged from 6 to 16 Gy (mean, 11.4 Gy) prescribed to the 90% isodose line. All regions of the spine received treatment: 2 cervical, 15 thoracic, and 1 lumbosacral. The volume of irradiated spinal elements receiving 30, 50, and 80% of the total dose ranged from 0.51 to 11.05, 0.19 to 6.34, and 0.06 to 1.73 cm, respectively. Treatment sessions (i.e., patient in to patient out of the room) varied between 20 and 40 minutes. Follow-up ranged from 4 to 36 months (median, 7 mo). Even though significant doses of radiation were delivered to all regions of the spinal cord and nerve roots coincidentally involved in the treatments, only one patient in this series developed progressive symptoms possibly attributable to a toxic effect of th...Continue Reading

References

Jun 1, 1975·Cancer·W M WaraJ G Schwade
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·B EmamiM Wesson
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·A J van der Kogel
Jan 7, 2003·Medical Physics·Fang-Fang YinJae Ho Kim
Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·Martin J MurphyJohn R Adler
Jan 10, 2004·Medical Physics·Hui YanJae Ho Kim
Aug 27, 2004·Neurosurgical Focus·Oren N GottfriedWilliam T Couldwell
Jun 11, 2005·Journal of Neurosurgery. Spine·Jeffrey W DegenFraser C Henderson

❮ Previous
Next ❯

Citations

Sep 30, 2008·Neurosurgical Review·Florian H EbnerMarcos Tatagiba
Jun 24, 2009·Current Treatment Options in Oncology·Wesley HsuJean-Paul Wolinsky
May 15, 2008·Nature Clinical Practice. Oncology·Pantaleo Romanelli, John R Adler
Dec 10, 2009·Nature Reviews. Clinical Oncology·Simon S LoRobert D Timmerman
Sep 3, 2010·Nature Reviews. Clinical Oncology·Dirk Rades, Janet L Abrahm
Jul 24, 2014·CNS Oncology·James K C LiuMark H Bilsky
Aug 27, 2014·Clinical Neurology and Neurosurgery·Mohamad BydonDaniel M Sciubba
Jul 18, 2014·Neurosurgery·Peter C Gerszten
Nov 1, 2012·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Michael AthanassacopoulosSpyridon G Pneumaticos
May 28, 2013·The Oncologist·Ilya LauferMark H Bilsky
Dec 26, 2006·Expert Review of Neurotherapeutics·Simon S LoEhud Mendel
May 19, 2009·Expert Review of Anticancer Therapy·Simon S LoRobert D Timmerman
May 18, 2010·Expert Review of Anticancer Therapy·Kevin ShiueSimon S Lo
Dec 24, 2015·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Carlo GrecoZvi Fuks
Sep 11, 2012·Cancer Treatment Reviews·Aashish D BhattShiao Y Woo
Jul 16, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ran Harel, Lilyana Angelov
Jul 29, 2009·Orthopedics·Andreas F MavrogenisPanayiotis J Papagelopoulos
Aug 5, 2008·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Arjun SahgalLijun Ma
Jun 3, 2008·International Journal of Radiation Oncology, Biology, Physics·Arjun SahgalEric L Chang
Jan 22, 2008·Surgical Neurology·Daniel RefaiPaul Santiago
Dec 25, 2007·Neurosurgery Clinics of North America·Neal LutherRoger Härtl
Nov 23, 2006·Hematology/oncology Clinics of North America·Mark Bilsky, Michelle Smith
Jan 3, 2014·Cancer·John P KirkpatrickFang-Fang Yin
Jun 27, 2014·The Journal of the American Academy of Orthopaedic Surgeons·Alok D SharanMark H Bilsky
Apr 15, 2014·Neurological Research·Ran Harel, Leor Zach
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·Matthias GuckenbergerMichael Flentje
Oct 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Shari DamastYoshiya Yamada
Apr 16, 2015·Radiation Oncology Journal·Samuel RyuRaphael Davis
Jan 31, 2015·Journal of Neurosurgery. Spine·Berkeley G BateJason Weaver
Sep 10, 2014·World Neurosurgery·Alexander TuchmanMichael L J Apuzzo
Mar 8, 2012·Journal of Korean Neurosurgical Society·Seil Sohn, Chun Kee Chung
May 23, 2016·International Journal of Radiation Oncology, Biology, Physics·Randa TaoAmol J Ghia
Aug 2, 2016·International Journal of Radiation Oncology, Biology, Physics·Kristin J RedmondArjun Sahgal
Oct 30, 2016·International Journal of Radiation Oncology, Biology, Physics·Houda BahigLaura Masucci
Oct 30, 2016·Journal of Neurosurgery. Spine·Jacob A MillerLilyana Angelov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.